國家衛生研究院 NHRI:Item 3990099045/5858
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 968610      線上人數 : 868
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/5858


    題名: Impact of derepressed AmpC beta-Lactamase ACT-9 on the clinical efficacy of ertapenem
    其他題名: Impact of Derepressed AmpC β-Lactamase ACT-9 on the Clinical Efficacy of Ertapenem
    作者: Lee, YT;Chen, TL;Siu, LK;Chen, CP;Fung, CP
    貢獻者: Division of Infectious Diseases
    摘要: An in vivo development of Pantoea agglomerans mutants (isolates PA2-4) with reduced ertapenem susceptibility from isolate PA1 was associated with an inadequate clinical response to ertapenem therapy. All the four isolates harbored the bla(ACT-9) AmpC beta-lactamase gene. However, a loss-of-function mutation in the ampD gene in PA2-4, but not PA1, led to derepressed ACT-9. The reduced ertapenem susceptibility caused by derepressed ACT-9 was confirmed with an ampD-knockout mutant of PA1.
    日期: 2011-09
    關聯: Antimicrobial Agents and Chemotherapy. 2011 Sep;55(9):4440-4442.
    Link to: http://dx.doi.org/10.1128/aac.00271-11
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000293953900074
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80051808646
    顯示於類別:[蕭樑基] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PB2011071807.pdf506KbAdobe PDF378檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋